Skip to Main Content

A Different Model — Not a Different Marketing Pitch.

Many PBMs claim transparency.

We operate it.

What "Transparent" Means at a Traditional PBM

They will show you a report. Selectively. After the fact. With a portal that displays what the PBM chooses to display.

Reports are pre-built. Data is curated. Audit rights are toothless or non-existent.

Rebates are partially or wholly retained. Formulary decisions are influenced by manufacturer rebate revenue. 

What "Transparent" Means at Appro-Rx

There is literally no hidden economic layer to report. Compensation is fully disclosed and disconnected from drug cost. The PBM cannot profit when costs rise or volume increases.

Plan sponsors receive their actual claims data — pharmacy and medical, real-time — and contractually-enforceable audit rights.

100% rebate pass-through to the plan sponsor. Formulary decisions are governed by clinical efficacy and total cost of care — not by rebate economics. 

 

Traditional PBM vs APPRO-RX

Revenue Model

Traditional PBM
Spread + retained rebates = profits from higher drug costs

Appro-Rx
Fixed disclosed PMPM fee — same revenue regardless of drug cost

 

Ownership

Traditional PBM
Owns pharmacies, mail order, specialty — inherent conflicts

Appro-Rx
Owns nothing — assembles best-in-class, replaceable components

 

Rebates

Traditional PBM
Retained or partially retained — pricing obscured

Appro-Rx
100% pass-through — no retained rebates, ever

 

Guarantee

Traditional PBM
Backward-looking, narrow, engineered to be met

Appro-Rx
Forward-looking PMPM cap — PBM absorbs overage 

 

Data Access


Traditional PBM
Pre-built reports showing what the PBM selects


Appro
-Rx
Full pharmacy + medical claims, real-time, audit rights

 

Specialty Drugs


Traditional PBM
Fights alternative sourcing — protects rebate revenue


Appro
-Rx
Enables ethical specialty access — no conflict with lower drug cost 

 

Clinical Programs


Traditional PBM
Templated — same logic across all populations 


Appro
-Rx
Pharmacist-led, customized to each group's drug mix and risk

 

CAA 2026 Posture


Traditional PBM
Scrambling to comply with new rebate pass-through law


Appro
-Rx
Already compliant — built this way since 2011

 

 

The PMPM Guarantee Removes Rebates From the Equation.

Under the Appro-Rx PMPM Guarantee, rebates stop mattering to the plan. The cost is fixed upfront. If rebates underperform, the guarantee covers the gap. The PBM cannot profit from higher list prices. This functionally eliminates rebate dependence without pretending rebates do not exist — it removes their role in budgeting, in PBM profit, and in plan risk. Which is exactly what policymakers and employers actually want, but have struggled to articulate

 

 

We Are a PBM.

We Are Also Something More.

Appro-Rx fits the PBM regulatory definition. But the operating model is closer to that of a Pharmacy Benefit Orchestrator: an entity that integrates and governs best-in-class components on behalf of the plan, rather than owning and selling those components for its own profit. The result is a PBM with the regulatory clarity employers and brokers need, and the structural neutrality the market has been asking for. 

 

 

Want to See How the Model Performs Against Yours?

Submit a recent pharmacy claims extract. We deliver a free, no-obligation, apples-to-apples cost comparison and PMPM projection — usually within days, not weeks. 

 

 

Request Your Claims Analysis


We Don't Own the Pharmacies We Manage.

That Changes Everything.

Most PBMs are vertically integrated. They own the pharmacies, the mail order, the specialty distribution, the rebate flows, and the prior authorization systems they manage. That ownership creates inherent conflicts that cannot be fully resolved — because their revenue depends on the very opacity and complexity they claim to reduce. 

Appro-Rx is engineered the opposite way. We deliberately separate control from ownership. The Appro-Rx model functions like an assembly plant: we select best-in-class components for each function — claims processing, pharmacy networks, analytics, clinical programs, formularies, prior-auth review, specialty access — and keep them seamlessly interchangeable. If a component underperforms, we replace it. The client gets the benefits of a full-service PBM with none of the conflicts of vertical integration.

This is not a feature. It is a fundamentally different business model — and it is why Appro-Rx can do what traditional PBMs structurally cannot. 

Copied!

^TOP
close
ModalContent
loading gif